Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

被引：0

作者：

E Näslund

B Barkeling

N King

M Gutniak

JE Blundell

JJ Holst

S Rössner

PM Hellström

机构：

[1] Danderyd Hospital,Division of Surgery

[2] Karolinska Institute,Department of Medical Physiology

[3] Obesity Unit,Department of Hepatology and Gastroenterology

[4] Huddinge University Hospital,undefined

[5] Biopsychology group,undefined

[6] Leeds University,undefined

[7] Multidisciplinary Pain Center,undefined

[8] Kronan,undefined

[9] University of Copenhagen,undefined

[10] Karolinska Hospital,undefined

来源：

International Journal of Obesity | 1999年 / 23卷

关键词：

appetite; food intake; gastric emptying; insulin; universal eating monitor;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

BACKGROUND: Peripheral administration of glucagon-like peptide-1 (GLP-1) for four hours, to normal weight and obese humans, decreases food intake and suppresses appetite.

引用

页码：304 / 311

页数：7